Ireland
--:--IST
Recruiting Not applicable

Verbal Analgesia Versus Standard Care for Pain Control in Women With Primary Infertility Undergoing Office Hysteroscopy

NCT07325994 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2025-10-20
Last updated
2026-01-08

Condition(s) studied

Hysteroscopy

Investigational drug(s) / intervention(s)

verbal analgesiastandard care

verbal analgesia: Providers will deliver a standardized verbal analgesia script in a calm, slow-paced, supportive tone, synchronized to procedural steps: * Scope introduction (introitus → external os): "You may feel light pressure as the camera enters-keep a slow, steady breath; you are doing well." * Cervical passage (internal os): "A brief pinch or cramp may happen now; it will pass quickly-breathe in slowly, and out." * Uterine entry and distension: "A feeling of fullness is expected; stay with your breath-it eases in moments." * Cavity inspection: "You may notice short waves of cramp; they are normal and brief-you're managing this well." * Withdrawal: "We are nearly finished-slow exhale as we come out. That's it, you did great." Providers will undergo training to ensure fidelity. All participants will receive ibuprofen 600 mg orally one hour before hysteroscopy as standard analgesia.

standard care: Providers will use neutral, procedural statements without supportive phrasing, e.g., "Starting the camera now," "Passing the cervix," "Entering the uterus," "Inspecting the cavity," "Withdrawing the camera.". All participants will receive ibuprofen 600 mg orally one hour before hysteroscopy as standard analgesia.

Study summary

Office hysteroscopy is a cornerstone in the diagnostic evaluation of infertile women, enabling direct visualization of the uterine cavity for identifying intrauterine pathology. The vaginoscopic ("no-touch") approach, which eliminates the use of a speculum and tenaculum, is increasingly adopted due to improved tolerability, higher success rates, and reduced pain compared to conventional methods.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
40 Years
Healthy volunteers
No
Inclusion Criteria: * o Women aged 18-40 years. * Diagnosis of primary infertility (failure to conceive after ≥12 months of unprotected intercourse). * Indication for diagnostic office hysteroscopy. * Regular menstrual cycles. Exclusion Criteria: * o Secondary infertility. * Known pelvic infection, cervicitis, or vaginitis. * Use of analgesics within 8 hours prior to procedure. * Cervical stenosis, prior failed hysteroscopy, or known uterine anomaly. * Contraindication to NSAIDs * Pregnancy or suspected pregnancy.

Primary outcome measure(s)

  • pain during OH — During the procedure (immediately after insertion of hysteroscope, assessed within 5 minutes
    It will be measured by 0-10 numerical rating scale where 0 indicates no pain and 10 worst pain imaginable

Trial sites (1)

FacilityCityRegionStatus
Al Gezeera Hospital Giza Egypt Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07325994 on ClinicalTrials.gov ↗ ← All trials in Egypt